While CD94 expression was infrequent overall, its detection in a subset of T-CLL cases highlights the need for larger studies to determine its diagnostic and therapeutic value in canine leukemia and lymphoma. This evidence concerns the gene KLRD1 and B-cell chronic lymphocytic leukemia.